Lung Cancer

August 12, 2015August 12, 2015

Diplomat Pharmacy To Offer IRESSA as First-line Treatment for Non-small Cell Lung Cancer

Lung Cancer, News

Diplomat Pharmacy, Inc., a company focused on medication management programs for people with complex chronic diseases, recently announced that IRESSA® (gefitinib), a recently approved drug by the U.S. Food and ... Read more

August 11, 2015October 28, 2015

New Experimental Lung Cancer Therapy Overstimulates and Kills Cancer Cells

Lung Cancer, News

In the photo shown, cancer cells were treated with a control (left) and the overstimulating compound MCB-613 (right). CREDIT Lei Wang A new, potentially promising drug overstimulates proteins that are needed ... Read more

July 31, 2015July 31, 2015

New Mechanism Underlying Lung Cancer Therapeutics Resistance Discovered

Lung Cancer, News

In two novel reports entitled “MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC” and “A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer” published in the ... Read more

July 30, 2015July 30, 2015

Increases in Telomere Length Associated With Double Risk for Lung Cancer

Lung Cancer, News

In a new study entitled “Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study,” researchers report that long telomeres are associated with an increased risk ... Read more

July 29, 2015July 29, 2015

Study Finds That Olprinone Reduces Risk of Atrial Fibrillation After Lung Cancer Surgery

Lung Cancer, News

Results from a recent study published in the journal CHEST show that the administration of olprinone continuously during lung cancer surgery reduces the risk for atrial fibrillation in patients with ... Read more

July 21, 2015July 21, 2015

European Commission Approves Nivolumab BMS by Bristol-Myers Squibb for NSCLC

Lung Cancer, News

Bristol-Myers Squibb Company recently announced the European Commission has granted approval of Nivolumab BMS as an effective post-chemotherapy treatment for locally advanced or metastatic squamous (SQ) non-small cell lung cancer ... Read more

July 17, 2015July 17, 2015

New Biopsy System Offers Improved Performance For Diagnosing Lung Cancer

Lung Cancer, News

Medtronic, a leading company in medical technology, is now offering the GenCut core biopsy system together with superDimension(TM) navigation system for lung tissue biopsies. Medtronic’s superDimension navigation system allows pulmonologists ... Read more

July 15, 2015July 15, 2015

Lung Cancer Patients That Quit Smoking Live Longer, According To Study

Lung Cancer, News

Tobacco cessation offers a proven survival benefit for lung cancer patients who quit smoking shortly before or after diagnosis, no matter how severe the disease is. The results from the Roswell Park Cancer Institute ... Read more

July 14, 2015July 14, 2015

Iressa (gefitinib) Now FDA-Approved for Metastatic Lung Cancer

Lung Cancer, News

Iressa (gefitinib) by AstraZeneca Pharmaceuticals will soon be available as another first-line treatment option for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are composed of certain types of epidermal ... Read more

July 10, 2015July 10, 2015

Necitumumab Combined with Gemcitabine and Cisplatin Closer to Becoming First-Line Therapy in Squamous NSCLC

Lung Cancer, News

Recently, the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC), whose main function is to evaluate both safety and effectiveness of human drugs (already in the market ... Read more